Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
50
DH Quote, Financials, Valuation and Earnings
Last price:
$2.80
Seasonality move
:
-15.11%
Day range:
$2.61 - $2.73
52-week range:
$2.15 - $5.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.23x
P/B ratio:
0.98x
Volume:
462.9K
Avg. volume:
482.8K
1-year change:
-35.93%
Market cap:
$280M
Revenue:
$252.2M
EPS (TTM):
-$1.68
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp.
|
$59.5M | $0.06 | -4.65% | -- | $3.75 |
|
CERT
Certara, Inc.
|
$104.6M | $0.11 | 3.04% | 150.07% | $12.54 |
|
DRIO
DarioHealth Corp.
|
$5.7M | -$2.42 | -32.08% | -68.96% | $18.25 |
|
GDRX
GoodRx Holdings, Inc.
|
$194.5M | $0.09 | -2.9% | 420.34% | $4.88 |
|
NRC
National Research Corp.
|
-- | -- | -- | -- | -- |
|
SPOK
Spok Holdings, Inc.
|
$35.9M | $0.24 | 2.09% | 18.18% | $20.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp.
|
$2.71 | $3.75 | $280M | -- | $0.00 | 0% | 1.23x |
|
CERT
Certara, Inc.
|
$8.85 | $12.54 | $1.4B | 131.11x | $0.00 | 0% | 3.43x |
|
DRIO
DarioHealth Corp.
|
$10.49 | $18.25 | $25.2M | -- | $0.00 | 0% | 5.82x |
|
GDRX
GoodRx Holdings, Inc.
|
$2.69 | $4.88 | $913.1M | 31.32x | $0.00 | 0% | 1.23x |
|
NRC
National Research Corp.
|
$18.97 | -- | $429.8M | 26.92x | $0.16 | 2.74% | 3.11x |
|
SPOK
Spok Holdings, Inc.
|
$13.08 | $20.00 | $269.4M | 16.34x | $0.31 | 9.56% | 1.94x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DH
Definitive Healthcare Corp.
|
38.11% | 3.167 | 33.53% | 1.44x |
|
CERT
Certara, Inc.
|
22.36% | 0.910 | 15.74% | 1.94x |
|
DRIO
DarioHealth Corp.
|
29.69% | 1.040 | 75.99% | 3.72x |
|
GDRX
GoodRx Holdings, Inc.
|
47.58% | 0.637 | 37.77% | 2.62x |
|
NRC
National Research Corp.
|
84.83% | 2.343 | 28.57% | 0.39x |
|
SPOK
Spok Holdings, Inc.
|
4.71% | 0.927 | 2.07% | 0.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp.
|
$36.9M | -$3.4M | -37.23% | -52.54% | -5.63% | $13.4M |
|
CERT
Certara, Inc.
|
$50.9M | $6.8M | 0.79% | 1.02% | 6.53% | $25.5M |
|
DRIO
DarioHealth Corp.
|
$3M | -$9.5M | -28.66% | -41.55% | -189.42% | -$7.4M |
|
GDRX
GoodRx Holdings, Inc.
|
$161.2M | $26.4M | 2.63% | 4.78% | 13.48% | $58M |
|
NRC
National Research Corp.
|
$20M | $7.7M | 17.01% | 61.55% | 22.36% | $10.2M |
|
SPOK
Spok Holdings, Inc.
|
$20M | $4.5M | 10.33% | 10.88% | 13.38% | $7.6M |
Definitive Healthcare Corp. vs. Competitors
-
Which has Higher Returns DH or CERT?
Certara, Inc. has a net margin of -29.63% compared to Definitive Healthcare Corp.'s net margin of 1.46%. Definitive Healthcare Corp.'s return on equity of -52.54% beat Certara, Inc.'s return on equity of 1.02%.
Company Gross Margin Earnings Per Share Invested Capital DHDefinitive Healthcare Corp.61.48% -$0.14 $565.1M CERTCertara, Inc.48.67% $0.01 $1.4B -
What do Analysts Say About DH or CERT?
Definitive Healthcare Corp. has a consensus price target of $3.75, signalling upside risk potential of 38.38%. On the other hand Certara, Inc. has an analysts' consensus of $12.54 which suggests that it could grow by 41.71%. Given that Certara, Inc. has higher upside potential than Definitive Healthcare Corp., analysts believe Certara, Inc. is more attractive than Definitive Healthcare Corp..
Company Buy Ratings Hold Ratings Sell Ratings DHDefinitive Healthcare Corp.3 9 0 CERTCertara, Inc.6 7 0 -
Is DH or CERT More Risky?
Definitive Healthcare Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Certara, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DH or CERT?
Definitive Healthcare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Certara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Definitive Healthcare Corp. pays 0.87% of its earnings as a dividend. Certara, Inc. pays out -- of its earnings as a dividend. Definitive Healthcare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DH or CERT?
Definitive Healthcare Corp. quarterly revenues are $60M, which are smaller than Certara, Inc. quarterly revenues of $104.6M. Definitive Healthcare Corp.'s net income of -$17.8M is lower than Certara, Inc.'s net income of $1.5M. Notably, Definitive Healthcare Corp.'s price-to-earnings ratio is -- while Certara, Inc.'s PE ratio is 131.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Definitive Healthcare Corp. is 1.23x versus 3.43x for Certara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHDefinitive Healthcare Corp.1.23x -- $60M -$17.8M CERTCertara, Inc.3.43x 131.11x $104.6M $1.5M
-
Which has Higher Returns DH or DRIO?
DarioHealth Corp. has a net margin of -29.63% compared to Definitive Healthcare Corp.'s net margin of -41.48%. Definitive Healthcare Corp.'s return on equity of -52.54% beat DarioHealth Corp.'s return on equity of -41.55%.
Company Gross Margin Earnings Per Share Invested Capital DHDefinitive Healthcare Corp.61.48% -$0.14 $565.1M DRIODarioHealth Corp.60.22% -$3.05 $106.6M -
What do Analysts Say About DH or DRIO?
Definitive Healthcare Corp. has a consensus price target of $3.75, signalling upside risk potential of 38.38%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.25 which suggests that it could grow by 73.98%. Given that DarioHealth Corp. has higher upside potential than Definitive Healthcare Corp., analysts believe DarioHealth Corp. is more attractive than Definitive Healthcare Corp..
Company Buy Ratings Hold Ratings Sell Ratings DHDefinitive Healthcare Corp.3 9 0 DRIODarioHealth Corp.3 1 0 -
Is DH or DRIO More Risky?
Definitive Healthcare Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.716%.
-
Which is a Better Dividend Stock DH or DRIO?
Definitive Healthcare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Definitive Healthcare Corp. pays 0.87% of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend. Definitive Healthcare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DH or DRIO?
Definitive Healthcare Corp. quarterly revenues are $60M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Definitive Healthcare Corp.'s net income of -$17.8M is lower than DarioHealth Corp.'s net income of -$2.1M. Notably, Definitive Healthcare Corp.'s price-to-earnings ratio is -- while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Definitive Healthcare Corp. is 1.23x versus 5.82x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHDefinitive Healthcare Corp.1.23x -- $60M -$17.8M DRIODarioHealth Corp.5.82x -- $5M -$2.1M
-
Which has Higher Returns DH or GDRX?
GoodRx Holdings, Inc. has a net margin of -29.63% compared to Definitive Healthcare Corp.'s net margin of 0.57%. Definitive Healthcare Corp.'s return on equity of -52.54% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.
Company Gross Margin Earnings Per Share Invested Capital DHDefinitive Healthcare Corp.61.48% -$0.14 $565.1M GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B -
What do Analysts Say About DH or GDRX?
Definitive Healthcare Corp. has a consensus price target of $3.75, signalling upside risk potential of 38.38%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.88 which suggests that it could grow by 81.54%. Given that GoodRx Holdings, Inc. has higher upside potential than Definitive Healthcare Corp., analysts believe GoodRx Holdings, Inc. is more attractive than Definitive Healthcare Corp..
Company Buy Ratings Hold Ratings Sell Ratings DHDefinitive Healthcare Corp.3 9 0 GDRXGoodRx Holdings, Inc.6 5 0 -
Is DH or GDRX More Risky?
Definitive Healthcare Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.004%.
-
Which is a Better Dividend Stock DH or GDRX?
Definitive Healthcare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Definitive Healthcare Corp. pays 0.87% of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend. Definitive Healthcare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DH or GDRX?
Definitive Healthcare Corp. quarterly revenues are $60M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. Definitive Healthcare Corp.'s net income of -$17.8M is lower than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Definitive Healthcare Corp.'s price-to-earnings ratio is -- while GoodRx Holdings, Inc.'s PE ratio is 31.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Definitive Healthcare Corp. is 1.23x versus 1.23x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHDefinitive Healthcare Corp.1.23x -- $60M -$17.8M GDRXGoodRx Holdings, Inc.1.23x 31.32x $196M $1.1M
-
Which has Higher Returns DH or NRC?
National Research Corp. has a net margin of -29.63% compared to Definitive Healthcare Corp.'s net margin of 11.54%. Definitive Healthcare Corp.'s return on equity of -52.54% beat National Research Corp.'s return on equity of 61.55%.
Company Gross Margin Earnings Per Share Invested Capital DHDefinitive Healthcare Corp.61.48% -$0.14 $565.1M NRCNational Research Corp.57.82% $0.18 $94.4M -
What do Analysts Say About DH or NRC?
Definitive Healthcare Corp. has a consensus price target of $3.75, signalling upside risk potential of 38.38%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Definitive Healthcare Corp. has higher upside potential than National Research Corp., analysts believe Definitive Healthcare Corp. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings DHDefinitive Healthcare Corp.3 9 0 NRCNational Research Corp.0 0 0 -
Is DH or NRC More Risky?
Definitive Healthcare Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.
-
Which is a Better Dividend Stock DH or NRC?
Definitive Healthcare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.74% to investors and pays a quarterly dividend of $0.16 per share. Definitive Healthcare Corp. pays 0.87% of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios DH or NRC?
Definitive Healthcare Corp. quarterly revenues are $60M, which are larger than National Research Corp. quarterly revenues of $34.6M. Definitive Healthcare Corp.'s net income of -$17.8M is lower than National Research Corp.'s net income of $4M. Notably, Definitive Healthcare Corp.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 26.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Definitive Healthcare Corp. is 1.23x versus 3.11x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHDefinitive Healthcare Corp.1.23x -- $60M -$17.8M NRCNational Research Corp.3.11x 26.92x $34.6M $4M
-
Which has Higher Returns DH or SPOK?
Spok Holdings, Inc. has a net margin of -29.63% compared to Definitive Healthcare Corp.'s net margin of 9.46%. Definitive Healthcare Corp.'s return on equity of -52.54% beat Spok Holdings, Inc.'s return on equity of 10.88%.
Company Gross Margin Earnings Per Share Invested Capital DHDefinitive Healthcare Corp.61.48% -$0.14 $565.1M SPOKSpok Holdings, Inc.58.95% $0.15 $156.1M -
What do Analysts Say About DH or SPOK?
Definitive Healthcare Corp. has a consensus price target of $3.75, signalling upside risk potential of 38.38%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 60.55%. Given that Spok Holdings, Inc. has higher upside potential than Definitive Healthcare Corp., analysts believe Spok Holdings, Inc. is more attractive than Definitive Healthcare Corp..
Company Buy Ratings Hold Ratings Sell Ratings DHDefinitive Healthcare Corp.3 9 0 SPOKSpok Holdings, Inc.1 0 0 -
Is DH or SPOK More Risky?
Definitive Healthcare Corp. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.
-
Which is a Better Dividend Stock DH or SPOK?
Definitive Healthcare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.56% to investors and pays a quarterly dividend of $0.31 per share. Definitive Healthcare Corp. pays 0.87% of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend. Definitive Healthcare Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Spok Holdings, Inc.'s is not.
-
Which has Better Financial Ratios DH or SPOK?
Definitive Healthcare Corp. quarterly revenues are $60M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Definitive Healthcare Corp.'s net income of -$17.8M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, Definitive Healthcare Corp.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Definitive Healthcare Corp. is 1.23x versus 1.94x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHDefinitive Healthcare Corp.1.23x -- $60M -$17.8M SPOKSpok Holdings, Inc.1.94x 16.34x $33.9M $3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
